G.P. Gupta, J. Massague, Cancer metastasis: building a framework. Cell 127(4), 679–695 (2006)
D. Varon, E. Shai, Platelets and their microparticles as key players in pathophysiological responses. J. Thromb. Haemost 13(Suppl 1), S40–S46 (2015)
M. Dovizio et al., Platelets and extracellular vesicles in cancer: diagnostic and therapeutic implications. Cancer Metastasis Rev 37(2–3), 455–467 (2018)
P.H. Liu, T.I. Huo, R.A. Miksad, Hepatocellular Carcinoma with Portal Vein Tumor involvement: best management strategies. Semin Liver Dis 38(3), 242–251 (2018)
P. Kanikarla-Marie et al., Platelets, circulating tumor cells, and the circulome. Cancer Metastasis Rev 36(2), 235–248 (2017)
L.J. Gay, B. Felding-Habermann, Contribution of platelets to tumour metastasis. Nat. Rev. Cancer 11(2), 123–134 (2011)
X. Zhong et al., Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy. Mol. Cancer 19(1), 15 (2020)
A.T. Franco, A. Corken, J. Ware, Platelets at the interface of thrombosis, inflammation, and cancer. Blood 126(5), 582–588 (2015)
D.G. Menter et al., Platelet “first responders” in wound response, cancer, and metastasis. Cancer Metastasis Rev 36(2), 199–213 (2017)
K.J. Luzzi et al., Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol 153(3), 865–873 (1998)
K. Suzuki-Inoue, Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin. Blood 134(22), 1912–1918 (2019)
A. Takemoto, K. Miyata, N. Fujita, Platelet-activating factor podoplanin: from discovery to drug development. Cancer Metastasis Rev 36(2), 225–234 (2017)
K. Suzuki-Inoue, M. Osada, Y. Ozaki, Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood. J. Thromb. Haemost 15(2), 219–229 (2017)
L. Yu et al., Bidirectional interaction between cancer cells and platelets provides potential strategies for cancer therapies. Front. Oncol 11, 764119 (2021)
X. Wang et al., Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis. Thromb. Res 200, 72–80 (2021)
Y. Kato et al., Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2. Cancer Sci 99(1), 54–61 (2008)
T. Shirai et al., C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice. J. Thromb. Haemost 15(3), 513–525 (2017)
J.M. Ponert et al., The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation. PLoS ONE 13(1), e0191303 (2018)
A. Mitrugno et al., The prothrombotic activity of cancer cells in the circulation. Blood Rev 30(1), 11–19 (2016)
E. Heinmoller et al., Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines. J. Cancer Res. Clin. Oncol 122(12), 735–744 (1996)
M. Zucchella et al., Human tumor cells cultured “in vitro” activate platelet function by producing ADP or thrombin. Haematologica 74(6), 541–545 (1989)
B.W. Steinert et al., Studies on the role of platelet eicosanoid metabolism and integrin alpha IIb beta 3 in tumor-cell-induced platelet aggregation. Int. J. Cancer 54(1), 92–101 (1993)
V.O. Melnikova et al., Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis. J. Biol. Chem 281(5), 2911–2922 (2006)
L.X. Yu et al., Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein. Nat. Commun 5, 5256 (2014)
Y. Ward et al., Platelets promote metastasis via binding tumor CD97 leading to bidirectional signaling that coordinates transendothelial migration. Cell. Rep 23(3), 808–822 (2018)
S. Miao et al., Cancer cell-derived immunoglobulin G activates platelets by binding to platelet FcgammaRIIa. Cell. Death Dis 10(2), 87 (2019)
B. Shao et al., Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome. Blood 118(15), 4015–4023 (2011)
S. Mezouar et al., Role of platelets in cancer and cancer-associated thrombosis: experimental and clinical evidences. Thromb. Res 139, 65–76 (2016)
F. Khan et al., Venous thromboembolism. Lancet 398(10294), 64–77 (2021)
A.K. Kakkar et al., Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 346(8981), 1004–1005 (1995)
A. Mitrugno et al., The role of coagulation and platelets in colon cancer-associated thrombosis. Am. J. Physiol. Cell. Physiol 316(2), C264–C273 (2019)
C.N. Hill et al., Deciphering the role of the coagulation cascade and autophagy in cancer-related thrombosis and metastasis. Front. Oncol 10, 605314 (2020)
R. Orellana et al., Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer 15, 290 (2015)
R. Lordan, A. Tsoupras, I. Zabetakis, Platelet activation and prothrombotic mediators at the nexus of inflammation and atherosclerosis: potential role of antiplatelet agents. Blood Rev 45, 100694 (2021)
S. Mondal et al., Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: a minireview. Eur. J. Med. Chem 194, 112260 (2020)
D. Alonso-Escolano et al., Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins. Br. J. Pharmacol 141(2), 241–252 (2004)
P. Jurasz et al., Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide. Cancer Res 61(1), 376–382 (2001)
M. Sebastiano et al., A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling. Blood 129(7), 883–895 (2017)
R. Li et al., Presence of intratumoral platelets is associated with tumor vessel structure and metastasis. BMC Cancer 14, 167 (2014)
M. Steinert et al., Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues. Am. J. Pathol 161(5), 1657–1667 (2002)
G. Lee et al., Molecular and immuno-characteristics of immunoglobulin-like glycoproteins in cancer cell-expressed biomarker, CA215. Immunol. Invest 41(4), 429–446 (2012)
M. Schlesinger, Role of platelets and platelet receptors in cancer metastasis. J. Hematol. Oncol 11(1), 125 (2018)
J.E. Geddings, N. Mackman, Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood 122(11), 1873–1880 (2013)
A.A. Khorana et al., Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J. Thromb. Haemost 6(11), 1983–1985 (2008)
R.S. Kasthuri et al., Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancer. Res. Pract. Thromb. Haemost 4(4), 636–643 (2020)
A. Ernst et al., Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival. Clin. Cancer Res 15(21), 6541–6550 (2009)
J. Riedl et al., Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism. Blood 129(13), 1831–1839 (2017)
留言 (0)